These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19784082)

  • 1. Neuroimaging study of placebo analgesia in humans.
    Qiu YH; Wu XY; Xu H; Sackett D
    Neurosci Bull; 2009 Oct; 25(5):277-82. PubMed ID: 19784082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiological mechanisms of placebo responses.
    Zubieta JK; Stohler CS
    Ann N Y Acad Sci; 2009 Mar; 1156():198-210. PubMed ID: 19338509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
    Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
    Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
    Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK
    Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo effects on human mu-opioid activity during pain.
    Wager TD; Scott DJ; Zubieta JK
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prefrontal non-opioid mechanism in placebo analgesia.
    Petrovic P; Kalso E; Petersson KM; Andersson J; Fransson P; Ingvar M
    Pain; 2010 Jul; 150(1):59-65. PubMed ID: 20399560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain.
    Amanzio M; Benedetti F; Porro CA; Palermo S; Cauda F
    Hum Brain Mapp; 2013 Mar; 34(3):738-52. PubMed ID: 22125184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the opioidergic descending pain control system underlies placebo analgesia.
    Eippert F; Bingel U; Schoell ED; Yacubian J; Klinger R; Lorenz J; Büchel C
    Neuron; 2009 Aug; 63(4):533-43. PubMed ID: 19709634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.
    Zubieta JK; Bueller JA; Jackson LR; Scott DJ; Xu Y; Koeppe RA; Nichols TE; Stohler CS
    J Neurosci; 2005 Aug; 25(34):7754-62. PubMed ID: 16120776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.
    Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK
    Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response.
    Jarcho JM; Feier NA; Labus JS; Naliboff B; Smith SR; Hong JY; Colloca L; Tillisch K; Mandelkern MA; Mayer EA; London ED
    Neuroimage Clin; 2016; 10():107-14. PubMed ID: 26759785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo analgesia: findings from brain imaging studies and emerging hypotheses.
    Kong J; Kaptchuk TJ; Polich G; Kirsch I; Gollub RL
    Rev Neurosci; 2007; 18(3-4):173-90. PubMed ID: 18019605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.
    Prossin A; Koch A; Campbell P; Laumet G; Stohler CS; Dantzer R; Zubieta JK
    Mol Psychiatry; 2022 Feb; 27(2):831-839. PubMed ID: 34716408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A voxel-based analysis of neurobiological mechanisms in placebo analgesia in rats.
    Zeng Y; Hu D; Yang W; Hayashinaka E; Wada Y; Watanabe Y; Zeng Q; Cui Y
    Neuroimage; 2018 Sep; 178():602-612. PubMed ID: 29883731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF
    PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo and opioid analgesia-- imaging a shared neuronal network.
    Petrovic P; Kalso E; Petersson KM; Ingvar M
    Science; 2002 Mar; 295(5560):1737-40. PubMed ID: 11834781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The placebo-reward hypothesis: dopamine and the placebo effect.
    de la Fuente-Fernández R
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S72-4. PubMed ID: 20083013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of brain mechanisms of placebo analgesia: consistent findings and unanswered questions.
    Atlas LY; Wager TD
    Handb Exp Pharmacol; 2014; 225():37-69. PubMed ID: 25304525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality trait predictors of placebo analgesia and neurobiological correlates.
    Peciña M; Azhar H; Love TM; Lu T; Fredrickson BL; Stohler CS; Zubieta JK
    Neuropsychopharmacology; 2013 Mar; 38(4):639-46. PubMed ID: 23187726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.